Select Equity Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Select Equity Group's RGEN Position: Q3 2022 in Review
Select Equity Group sold out of Repligen (RGEN) in Q3 2022, closing a stake of 4,418 shares — an estimated $717K sold.
Select Equity Group first reported a position in RGEN in Q1 2020 and held it in 10 quarters. The position peaked at $372M in Q3 2021. 433 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.
- Select Equity Group reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
- Select Equity Group sold 4,418 Repligen shares in Q3 2022, an estimated $717K.
- Select Equity Group first reported a position in Repligen in Q1 2020 and held it in 10 quarters.
- Select Equity Group's Repligen position peaked at $372M in Q3 2021.
- 433 funds tracked by Wall St. Rank held Repligen as of Q3 2022.
Based on Select Equity Group's 13F filing for Q3 2022, filed 14 Nov 2022.